Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nitin Mehrotra

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
NPJ Digital Medicine|July 15, 2022
Identifying and characterising sources of variability in digital outcome measures in Parkinson's diseaseGeorge Roussos, Teresa Ruiz Herrero, Derek L Hill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2015
FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphomaBarry W Miller, Donna Przepiorka, R Angelo de Claro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2015
FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell LymphomaHyon-Zu Lee, Virginia E Kwitkowski, Pedro L Del Valle, et al.
Clinical Pharmacology and Therapeutics|April 24, 2021
A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine-Rich Repeat Kinase 2 MutationMalidi Ahamadi, Nitin Mehrotra, Nathan Hanan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2014
FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancerLaleh Amiri-Kordestani, Gideon M Blumenthal, Qiang Casey Xu, et al.
Digital Biomarkers|January 14, 2021
Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory ScienceDiane Stephenson, Robert Alexander, Varun Aggarwal, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
NPJ Digital Medicine|July 15, 2022
Identifying and characterising sources of variability in digital outcome measures in Parkinson's diseaseGeorge Roussos, Teresa Ruiz Herrero, Derek L Hill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2015
FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphomaBarry W Miller, Donna Przepiorka, R Angelo de Claro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2015
FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell LymphomaHyon-Zu Lee, Virginia E Kwitkowski, Pedro L Del Valle, et al.
Clinical Pharmacology and Therapeutics|April 24, 2021
A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine-Rich Repeat Kinase 2 MutationMalidi Ahamadi, Nitin Mehrotra, Nathan Hanan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2014
FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancerLaleh Amiri-Kordestani, Gideon M Blumenthal, Qiang Casey Xu, et al.
Digital Biomarkers|January 14, 2021
Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory ScienceDiane Stephenson, Robert Alexander, Varun Aggarwal, et al.
Pageof 5